Moreover, when treated with proteasome inhibitors, the loss of H3K27 acetylation was significantly attenuated when HDAC3 was knocked down compared with nonsilencing multiple myeloma cells (Fig. 4F; Supplementary Fig. S5). Here, HDAC3 is linked to plasma cell myeloma.